Algo version: 0.98b
ZYNE is listed at the NASDAQ Exchange
ZYNE [ZYNE]
NASDAQ Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is ZYNE stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Zynerba Pharmaceuticals 10 years ago, but if you had invested on Wednesday 5th of August 2015 when the price was $16.25, you would have made a loss of $-14.95 per share or -92.00%

No, the average daily trading liquidity for Zynerba Pharmaceuticals is $882 003 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Zynerba Pharmaceuticals has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Zynerba Pharmaceuticals to be medium [0.6 out of 1]